Elon Musk’s feud with President Trump is first-rate tabloid fare. Musk’s money versus Trump’s power is a celebrity smackdown ...

U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for acute heart failure, this patent would provide protection to ...

US stock futures wavered on Wednesday as Wall Street digested more signs of an intensifying labor market slowdown and watched ...

President Trump on Tuesday suggested that his team would force Japan to accept higher tariffs of "30%, 35%, or whatever the ...

Research by non-partisan think-tank CBO forecasts that the bill’s massive cuts to Medicaid could leave 11.8 million Americans ...

BigBear.ai Holdings, Inc. (NYSE:BBAI) is one of the 10 Buzzing AI Stocks on Wall Street Right Now. On July 1, H.C. Wainwright ...

Markets are watching for signs the US will hammer out deals with the likes of the EU and Japan before a pause on Trump's ...

An analysis finds that a critical group of U.S. employers would face a direct cost of $82.3 billion from President Donald ...

Trump has threatened to impose a "30% or 35%" tariff on Japan if a deal between the two countries is not reached before next ...

Few companies have the ability to grow by leaps and bounds for decades at a time. Nu Holdings (NYSE: NU) is one of those rare businesses. Willing to look abroad to give your portfolio maximum growth ...

The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by rising obesity and type 2 diabetes incidences, the ...

Greggs has said it expects to report lower annual profit than last year as scorching temperatures in June impacted sales. The company told markets this morning that total sales in the first half of ...